Premium Information is available for this item - Upgrade for $1 a day
6505-01-337-0318
Usp Ceftazidime For Injection
6505013370318 013370318 CEPTAZ NDC00173-0415-00
INC: 42844 Ceftazidime For Injection
January 2023
6
Marketplace 6505-01-337-0318
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-337-0318 5+ Documents (More...)
6505-01-337-0318 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-337-0318
/fsg-65/fsc-6505/us 6505-01-337-0318 /fsg-65/fsc-6505/us 6505-01-337-0318 /fsg-65/fsc-6505/us 6505-01
-206-6138 6505-43-000-5930 https 343-2105 6505-01-337-0319 6505-17-056-4798 6505-01-336-6183 6505-01-337-0318
Usp Ceftazidime For Injection 6505013370318 19-001-0613 https/ fsc-6505/us 6505-01-337-0318 https
Usp Ceftazidime For Injection 6505013370318 us 6505-01-337-0318 /fsg-65/fsc-6505/us 6505-01 https
www.nsnlookup.com /fsg-65/fsc-6505/br 6505-19-001-0613 Ceftazidime For Injection 6505190010613 Injection 6505013370318
CEPTAZ Ceftazidime For Injection6505013370318 013370318 CEPTAZ 6505013002115 https//www.nsnlookup.com
Upgrade your Account Upgrade 6505-01-337-0318Usp Ceftazidime For Injection6505013370318 013370318 CEPTAZ
Upgrade your Account Upgrade 6505-01-337-0319Usp Ceftazidime For Injection6505013370319 013370319 CEPTAZ
CEPTAZ Ceftazidime For Injection6505013370318 013370318 CEPTAZ 6505013002115 https//www.nsnlookup.com
Restrictions 6505-01-337-0318
6505-01-337-0318 is a Usp Ceftazidime For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-337-0318
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-337-0318
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-337-0318
- Part Number
- Manufacturer
- Status
- NDC00173-0415-00
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- CEPTAZ
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-337-0318
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 2.000 Grams Ceftazidime, Anhydrous Equivalent
- Physical Form [AGXW]
- Powder
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 2.000 Grams Of Active Ingredient
- Total Primary Container Quantity [CSCW]
- 25
- Special Features [FEAT]
- With Hanging Device For Intravenous Administration
Management Data 6505-01-337-0318
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1992
- Veterans Administration (VA)
- PG
- Subscribe
- 1
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 25 Ea
- 00000000025EA
- K
Similar Supply Items to 6505-01-337-0318
Freight Information 6505-01-337-0318
6505-01-337-0318 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-337-0318 has a variance between NMFC and UFC when transported by rail and the description should be consulted.